<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Adverse effects of neuraxial analgesia and anesthesia for obstetrics
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Adverse effects of neuraxial analgesia and anesthesia for obstetrics
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Adverse effects of neuraxial analgesia and anesthesia for obstetrics
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gilbert J Grant, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David L Hepner, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marianna Crowley, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuraxial analgesia and anesthesia (ie, spinal, epidural, and combined spinal epidural) for labor and delivery are generally very safe, but all interventions are associated with adverse effects. The practice of obstetric anesthesia has evolved in large part to minimize such adverse effects. This topic will review the side effects and complications of neuraxial anesthetic techniques used for labor and delivery.
        </p>
        <p>
         Serious neurologic complications of neuraxial anesthesia (eg, meningitis, spinal epidural abscess, arachnoiditis, spinal cord injury) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/115387.html" rel="external">
          "Serious neurologic complications of neuraxial anesthesia procedures in obstetric patients"
         </a>
         .)
        </p>
        <p>
         The relevant anatomy, techniques, indications, contraindications, and physiologic effects of neuraxial analgesia and anesthesia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/89517.html" rel="external">
          "Overview of neuraxial anesthesia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H788021902">
         <span class="h1">
          SIDE EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The side effects of neuraxial analgesia and anesthesia result from the physiologic effects of neuraxial block or direct effects of the local anesthetics and/or opioids used for the techniques.
        </p>
        <p class="headingAnchor" id="H2344125203">
         <span class="h2">
          Hypotension
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuraxial anesthesia-induced sympathetic blockade causes vasodilation and decrease in venous return to the heart, which can result in maternal hypotension  (
         <a class="graphic graphic_figure graphicRef114864" href="/z/d/graphic/114864.html" rel="external">
          figure 1
         </a>
         ). A reduction in blood pressure can also occur with abrupt onset of pain relief, as may occur after intrathecal analgesic administration for combined spinal epidural (CSE) labor analgesia.
        </p>
        <p>
         Hypotension is usually defined as either systolic blood pressure &lt;100 mmHg or a reduction of &gt;20 percent from baseline. Hypotension is considered clinically significant if it is associated with maternal symptoms such as lightheadedness and nausea and/or deterioration of the fetal heart rate, a sign of compromised uteroplacental perfusion. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Goal blood pressure'
         </a>
         .)
        </p>
        <p>
         Patients are usually positioned with left uterine displacement during cesarean delivery, and after initiation of neuraxial labor analgesia, to avoid aortocaval compression and possible hypotension. The need for left uterine displacement in healthy parturients has been questioned. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Intraoperative positioning'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         –
         <strong>
         </strong>
         Hypotension occurs more commonly after onset of neuraxial anesthesia for cesarean delivery than after initiation of labor analgesia. Spinal anesthesia may result in quicker and more profound hypotension when compared with epidural anesthesia (see
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Hemodynamic management'
         </a>
         ). The reported incidence of hypotension (systolic blood pressure &lt;100 mmHg or &lt;80 percent of baseline) after spinal anesthesia for cesarean delivery is as high as 70 percent [
         <a href="#rid1">
          1
         </a>
         ], and can be reduced by fluid co-loading and prophylactic administration of vasopressors (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         or
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Hemodynamic management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hypotension occurs much less commonly after initiation of low dose neuraxial labor analgesia, with a reported incidence between zero and approximately 14 percent [
         <a href="#rid2">
          2-5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid loading
         </strong>
         –
         <strong>
         </strong>
         A practical strategy for avoiding hypotension during initiation of neuraxial anesthesia for cesarean delivery includes a rapid bolus of intravenous crystalloid (500 to 1000 mL) at the time of induction/neuraxial placement (co-load), in conjunction with administration of vasopressors. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Fluid management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Intravenous fluid loading is unnecessary with the low dose epidural techniques that are usually used for labor analgesia. In one study, there was no difference in hypotension between parturients who were randomly assigned to receive a one liter IV crystalloid bolus or no preload before initiation of epidural labor analgesia (ELA; 6 and 10 percent, respectively) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vasopressors
         </strong>
         –
         <strong>
         </strong>
         For prevention of neuraxial anesthesia-induced hypotension during cesarean delivery, for most patients we suggest prophylactic, titrated administration of low-dose
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         infusion (ie, starting at 50 mcg/min) with phenylephrine rescue boluses, along with crystalloid co-loading, aiming for maternal blood pressure close to baseline. Phenylephrine is the preferred vasopressor rather than
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         for most patients in this setting in the absence of bradycardia. Limited data suggest that
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         may be beneficial for prevention and treatment of spinal hypotension during cesarean delivery. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Vasopressors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Symptomatic hypotension during labor is usually easily treated with small IV doses of
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         (eg, 40 to 80 mcg) or
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         (eg, 5 to 10 mg) and IV fluids. Repeated doses of phenylephrine and/or ephedrine should be administered as needed until the hypotension is corrected. An infusion of phenylephrine is rarely required during low-dose neuraxial labor analgesia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Prophylactic administration of
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         or
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         prior to labor analgesia is not indicated when low-dose techniques are used.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1940945420">
         <span class="h2">
          Pruritus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pruritus is a common side effect of neuraxial opioid administration, and is more likely to occur in pregnant and postpartum women than in other patient populations [
         <a href="#rid7">
          7,8
         </a>
         ].
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          Fentanyl
         </a>
         and
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         are relatively lipid soluble and may cause pruritus in the legs, abdomen, and thorax.
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          Morphine
         </a>
         and
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         , which are much more water-soluble, may cause pruritus in the neck and head as well.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pruritus occurs more commonly after intrathecal opioid administration than after epidural administration, with a reported incidence of close to 100 percent for
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         , which is often used for CSE labor analgesia [
         <a href="#rid9">
          9-11
         </a>
         ]. In a meta-analysis of 11 trials involving 959 women, CSE was associated with more pruritus than low-dose epidural (average risk ratio [RR] 1.80; 95% CI 1.22-2.65) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The incidence of pruritus after neuraxial opioid administration is dose dependent [
         <a href="#rid12">
          12-17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The duration of pruritus after intrathecal or epidural administration of the lipid soluble opioids
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         and
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         is relatively brief compared to the duration of pruritus associated with neuraxial
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         and
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coadministration of local anesthetics (LAs) with opioids may reduce the incidence of pruritus [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The etiology of neuraxial opioid-induced pruritus is unclear, but it is not caused by histamine release [
         <a href="#rid18">
          18
         </a>
         ]. Thus, treatment with an antihistamine such as
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         is not indicated, as any benefit is due to sedation or perhaps placebo effect.
        </p>
        <p>
         The most effective treatment for opioid-induced pruritus is administration of a small dose of an opioid antagonist such as
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         (40 to 80 mcg intravenously [IV], or infusion at 0.25 to 1 mcg/kg/h IV [
         <a href="#rid19">
          19
         </a>
         ]),
         <a class="drug drug_general" data-topicid="9679" href="/z/d/drug information/9679.html" rel="external">
          naltrexone
         </a>
         (6 mg orally), or the mixed opioid agonist-antagonist
         <a class="drug drug_general" data-topicid="9676" href="/z/d/drug information/9676.html" rel="external">
          nalbuphine
         </a>
         (2.5 to 5 mg IV) [
         <a href="#rid20">
          20,21
         </a>
         ]. Higher doses or infusion of any opioid antagonist may reverse analgesia [
         <a href="#rid22">
          22
         </a>
         ]. Limited literature suggests that nalbuphine may be more effective for relief of pruritus than naloxone, but is associated with increased sedation [
         <a href="#rid21">
          21
         </a>
         ]. Practice for treatment of neuraxial opioid induced pruritus varies: one contributor on this topic administers nalbuphine 2.5 to 5 mg IV in this setting, whereas the other administers naloxone 40 to 80 mcg IV, repeated in five minutes if necessary, and patient controlled intravenous naloxone when indicated for prolonged pruritus.
        </p>
        <p>
         Other drugs that have been studied for the prevention and/or treatment of opioid induced pruritus include intravenous
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , serotonin antagonists, and glucocorticoids [
         <a href="#rid23">
          23
         </a>
         ]. A systematic review of randomized trials of treatment and/or prevention of opioid induced pruritus (neuraxial or systemic opioids) found that intravenous
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9679" href="/z/d/drug information/9679.html" rel="external">
          naltrexone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9676" href="/z/d/drug information/9676.html" rel="external">
          nalbuphine
         </a>
         , and
         <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">
          droperidol
         </a>
         were effective, based on overall low quality data [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Studies of the effect of serotonin (5-HT3) receptor antagonists on opioid induced pruritus have reported conflicting results. A meta-analysis of nine randomized trials involving patients who received intrathecal
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         for cesarean delivery reported that the incidence of pruritus was not reduced by prophylaxis with 5-HT3 receptor antagonists compared with placebo (81 percent versus 86 percent) [
         <a href="#rid25">
          25
         </a>
         ]. However, 5-HT3 receptor antagonists reduced the severity and need for treatment of pruritus, were effective for treatment of established pruritus, and reduced the incidence of postoperative nausea and vomiting and the need for rescue antiemetic therapy. Practice varies regarding administration of 5-HT3 receptor antagonists; one contributor on this topic routinely administers
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         after cord clamping because of its benefits and low incidence of side effects, and the other does not.
        </p>
        <p>
         For those laboring patients experiencing severe pruritus refractory to treatment, switching the epidural analgesic solution to one that is opioid-free is a reasonable option.
        </p>
        <p class="headingAnchor" id="H2151087578">
         <span class="h2">
          Nausea and vomiting
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nausea and vomiting occur commonly in the peripartum period, with or without neuraxial analgesia. Nausea may result from labor itself; nausea related to the pain of contractions tends to resolve after initiation of effective neuraxial analgesia. Nausea may also be a side effect of systemic opioid administration, or the result of one of several anesthesia-related causes, including the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypotension
         </strong>
         – Nausea and vomiting may be caused by hypotension during neuraxial labor analgesia, or more commonly during neuraxial anesthesia for cesarean delivery. Nausea usually resolves with correction of blood pressure, and rarely requires further treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuraxial opioids
         </strong>
         – Nausea is an uncommon side effect of neuraxial administration of the lipophilic opioids (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         ), which are often administered for labor analgesia, with a reported incidence &lt;2.5 percent [
         <a href="#rid26">
          26
         </a>
         ]. Nausea may be more likely with lipophilic opioids used for CSE compared with epidural labor analgesia [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Nausea and vomiting are more common after administration of neuraxial
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         , which is usually administered for post cesarean delivery pain. In a meta-analysis of studies of the effect of serotonin receptor antagonists for prevention of side effects of 0.1 to 0.2 mg intrathecal morphine, the reported incidence of postoperative nausea without prophylaxis was 30 to 37 percent, and the incidence of postoperative vomiting was 10 to 35 percent [
         <a href="#rid25">
          25
         </a>
         ]. Prophylactic
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         reduced the incidence and severity of nausea and vomiting, and the need for postoperative rescue antiemetic.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other drugs that are reported to reduce neuraxial opioid induced nausea and vomiting in various patient populations include
         <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">
          metoclopramide
         </a>
         [
         <a href="#rid27">
          27,28
         </a>
         ],
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         [
         <a href="#rid29">
          29,30
         </a>
         ], and transdermal
         <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">
          scopolamine
         </a>
         [
         <a href="#rid31">
          31
         </a>
         ]. An infusion of low dose
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         was used in one reported case of intractable nausea and vomiting associated with intrathecal
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Antiemetics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Neuraxial
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         may be administered for postcesarean delivery pain when
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         is unavailable. Most studies have reported an incidence of nausea and vomiting with hydromorphone similar to neuraxial morphine [
         <a href="#rid33">
          33-35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1665269139">
         <span class="h2">
          Urinary retention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urinary retention is a possible side effect of both neuraxial analgesia and anesthesia. Both neuraxial local anesthetics and neuraxial opioids can cause decreased ability to sense a full bladder and to void [
         <a href="#rid36">
          36
         </a>
         ]. Small observational [
         <a href="#rid37">
          37
         </a>
         ] and randomized trials [
         <a href="#rid38">
          38
         </a>
         ] have reported an association between ELA and intrapartum or postpartum urinary retention, though a cause and effect relationship has not been proven, and postpartum bladder dysfunction is common in patients who have no anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/127985.html" rel="external">
          "Overview of the postpartum period: Disorders and complications", section on 'Voiding difficulty and urinary retention'
         </a>
         .)
        </p>
        <p>
         Urinary retention may be less common with the low concentration epidural solutions that are commonly used, compared with the higher concentration solutions that were used in the past. In one trial, more patients randomly assigned to low dose labor analgesia (0.1%
         <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">
          bupivacaine
         </a>
         with
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ) were able to void spontaneously than those who received more concentrated epidural solutions (0.25% bupivacaine) (32 percent versus 11 percent) [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         Bladder distention should be considered if patients complain of breakthrough pain during labor analgesia, and bladder catheterization should be performed as necessary.
        </p>
        <p class="headingAnchor" id="H64683748">
         <span class="h2">
          Fever
         </span>
         <span class="headingEndMark">
          —
         </span>
         Randomized trials and observational studies have consistently reported an association between the use of epidural analgesia and rise in maternal temperature. The etiology of the temperature increase associated with epidural analgesia is incompletely understood. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4453.html" rel="external">
          "Intrapartum fever"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H885147716">
         <span class="h2">
          Shivering
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postpartum shivering is a common event, even in the absence of analgesia/anesthesia for labor and childbirth. (See
         <a class="medical medical_review" href="/z/d/html/6711.html" rel="external">
          "Overview of the postpartum period: Normal physiology and routine maternal care"
         </a>
         .)
        </p>
        <p>
         Shivering related to neuraxial anesthesia is not fully understood, but may be caused in part by sympathetic block-induced vasodilation, with redistribution of body heat from the core to the periphery [
         <a href="#rid40">
          40
         </a>
         ]. Shivering can be bothersome and can interfere with blood pressure monitoring. Patients may be warmed with heated blankets or forced air warming systems. Further treatment with intravenous
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          meperidine
         </a>
         (12.5 to 25 mg IV) may be used when necessary.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          Dexmedetomidine
         </a>
         may be an alternative for treating shivering related to neuraxial anesthesia, including during childbirth. In a randomized trial of 80 patients who had shivering during cesarean delivery with spinal or epidural anesthesia, a single dose of dexmedetomidine 30 mcg IV after delivery of the infant reduced the duration of shivering without hemodynamic effects or sedation [
         <a href="#rid41">
          41
         </a>
         ]. Shivering was eliminated within 15 minutes in 90 percent of patients who received dexmedetomidine, versus 22.5 percent of patients who received
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         .
        </p>
        <p class="headingAnchor" id="H2139289840">
         <span class="h1">
          COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3695555896">
         <span class="h2">
          Local anesthetic systemic toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Local anesthetic systemic toxicity (LAST) in obstetric anesthesia most commonly occurs after inadvertent injection of high volume of a high concentration of local anesthetic into an epidural vein. Pregnant patients, especially at term, are at increased risk for LAST because of the physiologic and hormonal changes of pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity", section on 'Patient risk factors'
         </a>
         .)
        </p>
        <p>
         LAST is uncommon during labor analgesia because of the low concentration of local anesthetics used for epidural labor analgesia (ELA).
        </p>
        <p>
         LAST primarily affects the central nervous system and cardiovascular system, and may be fatal. The clinical presentation, prevention, and management of LAST are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'The epidural test dose in obstetrics'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4141751120">
         <span class="h2">
          Inadequate anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Failed neuraxial block may be defined as inadequate analgesia/anesthesia following an epidural, spinal, or combined spinal–epidural (CSE) technique. The reported incidence of failed block varies, and may be affected by patient factors (eg, obesity, anatomic or postsurgical spine abnormalities), stage of labor, skill of the anesthesia clinician, the specific neuraxial technique, and/or technical factors (eg, equipment used, depth of catheter insertion).
        </p>
        <p>
         In one single institution review of anesthesia records and quality assurance data for approximately 12,500 neuraxial labor analgesia techniques, the overall failure rate was 12 percent, with a lower failure rate for CSE compared with epidural analgesia (10 versus 14 percent) [
         <a href="#rid42">
          42
         </a>
         ]. In the same review, seven percent of labor epidurals failed when used for cesarean delivery, and spinal anesthesia planned for cesarean delivery failed in 2.7 percent of patients. In another single institution prospective study of 250 parturients who received epidural analgesia, inadequate analgesia at 30 minutes after block initiation occurred in 17 percent of patients. [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         Management of inadequate analgesia during labor, and management of failed neuraxial anesthesia for cesarean delivery are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Clinician epidural top-ups'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Failed or inadequate neuraxial block'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3425892288">
         <span class="h2">
          Motor block
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuraxial administration of local anesthetics in high concentrations causes motor block, an undesirable side effect during labor. The drugs and administration techniques (eg, patient controlled epidural analgesia, programmed intermittent epidural bolus) for neuraxial analgesia are chosen in part to minimize motor block. (See
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Modes of drug administration'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Goals for neuraxial drug choice'
         </a>
         .)
        </p>
        <p>
         The drugs used for neuraxial labor analgesia techniques usually include a combination of dilute local anesthetic and a lipid soluble opioid. The combination allows the use of lower doses of each agent, thereby minimizing side effects, including motor block. Maintenance of motor function preserves the parturient's ability to push, may allow her to ambulate (if only to the bathroom), maintains maternal satisfaction, and may reduce the effects of neuraxial anesthesia on the incidence of instrumental delivery. (See
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Goals for neuraxial drug choice'
         </a>
         and
         <a class="local">
          'Effects on the progress and outcome of labor'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3747828545">
         <span class="h2">
          High neuraxial block
         </span>
         <span class="headingEndMark">
          —
         </span>
         Total spinal anesthesia can be a complication of either spinal or epidural anesthesia. It may result from the unrecognized and unintentional injection of medication intended for the epidural space into the subarachnoid or subdural space (via a malpositioned catheter or needle), transfer of medication from the epidural space into the subarachnoid space through a dural rent, or an overdose of medication injected into the subarachnoid space. The reported incidence in the obstetric population in the United States is 1 in 4336 blocks [
         <a href="#rid44">
          44
         </a>
         ]. A study of data from 2011 to 2014 from the United Kingdom Obstetric Surveillance System reported 66 cardiac arrests during approximately 2,350,000 pregnancies [
         <a href="#rid45">
          45
         </a>
         ]. The leading cause of cardiac arrest was a complication of obstetric anesthesia (nearly one in four pregnant patients who had cardiac arrest); 10 of the 17 arrests attributed to obstetric anesthesia resulted from total spinal anesthetic following de novo intrathecal block.
        </p>
        <p>
         High or total spinal block is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'High neuraxial block'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89517.html" rel="external">
          "Overview of neuraxial anesthesia", section on 'High or total spinal anesthesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1928065332">
         <span class="h2">
          Post dural puncture headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         Post dural puncture headache (PDPH; also called spinal headache or post lumbar puncture headache) is a positional headache (ie, worse when the patient sits or stands) that occurs because of leakage of cerebrospinal fluid (CSF) through a dural puncture. PDPH may occur after spinal anesthesia (ie, intentional dural puncture) or after unintentional dural puncture (UDP) with an epidural needle. The mechanism of headache after CSF leak is unclear, but appears to involve cerebral vasodilation and/or traction on intracranial structures. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Pathophysiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Clinical Features'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         –
         <strong>
         </strong>
         The rate of PDPH after dural puncture varies widely across patient populations; young pregnant women with a low body mass index (BMI) are at highest risk [
         <a href="#rid46">
          46
         </a>
         ]. A meta-analysis of 51 randomized and observational studies of PDPH in over 300,000 obstetric patients reported a risk of UDP of 1.5 percent, with a risk of PDPH of approximately 52 percent after UDP [
         <a href="#rid47">
          47
         </a>
         ]. The risk of PDPH after dural puncture with a spinal needle was 1.5 to 11.2 percent, and varied with the size and type of spinal needle. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Procedural risk factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         –
         <strong>
         </strong>
         Most PDPHs will resolve in 7 to 10 days if untreated. Conservative management with symptomatic therapy (eg, oral analgesics,
         <a class="drug drug_general" data-topicid="9213" href="/z/d/drug information/9213.html" rel="external">
          caffeine
         </a>
         ) may be indicated if the patient does not desire epidural blood patch (EBP) or if the headache is not severe [
         <a href="#rid48">
          48
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Treatment'
         </a>
         ). Intracranial hemorrhage should be suspected with a prolonged headache. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Epidural blood patch
         </strong>
         –
         <strong>
         </strong>
         The recommended treatment for severe, debilitating PDPH is epidural blood patch (EBP). The initial blood patch gives complete or partial relief in 95 percent of obstetric patients with PDPH, but the headache may recur. In one series, headache recurred in 31 percent of parturients who had an EBP for PDPH, and 28 percent received more than one EBP [
         <a href="#rid49">
          49
         </a>
         ]. EBP is performed by injecting the patient's blood into the epidural space to form a clot over the dural defect [
         <a href="#rid50">
          50,51
         </a>
         ]. EBP is thought to work by two mechanisms, initially by increasing the subarachnoid CSF pressure, and later by forming a fibrin plug that seals the hole in the dura and prevents further CSF leak [
         <a href="#rid52">
          52
         </a>
         ]. EBP is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Epidural blood patch'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Sphenopalatine ganglion block
         </strong>
         –
         <strong>
         </strong>
         A novel noninvasive approach to treating PDPH using an old technique, transnasal sphenopalatine ganglion block (SPGB), has been described [
         <a href="#rid53">
          53-56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Alternative treatments for PDPH'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Literature on the efficacy of SPGB is limited, consisting of case series and a small randomized trial. SPGB for PDPH is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Transnasal sphenopalatine block'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         As we await more robust prospective trials comparing SPGB with other treatments of PDPH, the author offers SPGB to all patients with PDPH because of its low risk. He suggests it particularly for patients who do not desire a blood patch, or for whom a blood patch is relatively or absolutely contraindicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other therapies to treat or prevent PDPHs have not been consistently efficacious.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prophylactic epidural blood patch
         </strong>
         – An EBP may be performed prophylactically, before a headache occurs after an inadvertent dural puncture. Blood is injected into the epidural catheter prior to its removal after delivery. The efficacy of prophylactic EBP is unclear. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Prevention of PDPH after dural puncture'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Spinal catheter
         </strong>
         – Threading an epidural catheter into the intrathecal space at the time of UDP has been advocated to reduce the incidence of PDPH. We do not routinely place an intrathecal catheter after UDP, but place intrathecal catheters selectively (eg, after a difficult epidural procedure). The efficacy of intrathecal catheter placement has not been established in randomized controlled trials, and most studies have reported no benefit of intrathecal catheter placement. (See
         <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">
          "Post dural puncture headache", section on 'Prevention of PDPH after dural puncture'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H695197385">
         <span class="h2">
          Pneumocephalus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Injection of air into the subarachnoid space during placement of neuraxial block may result in acute onset of severe headache and other neurologic signs and symptoms [
         <a href="#rid57">
          57
         </a>
         ]. This complication may occur with an unintentional dural puncture if air, rather than
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         , is used for loss of resistance to identify the epidural space. (See
         <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">
          "Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Epidural anesthesia technique'
         </a>
         .)
        </p>
        <p>
         A pneumocephalus headache can occur within a few seconds if the epidural procedure is performed with the patient in the sitting position, but may be delayed until she sits up if the epidural procedure is performed in the lateral decubitus position. Treatment of pneumocephalus headache is symptomatic. An EBP is of no value for this type of headache.
        </p>
        <p class="headingAnchor" id="H2702273914">
         <span class="h2">
          Spinal epidural hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hemorrhage into the neuraxis, a rare complication of spinal and epidural techniques, may occur if a blood vessel is punctured by a needle and/or catheter. Spinal epidural hematoma (SEH) can occur in any patient and may occur spontaneously without neuraxial instrumentation, but is more likely in patients with disorders of coagulation and in those receiving anticoagulants. The incidence of SEH appears to be significantly lower in obstetric patients than in other populations. Retrospective studies have reported an incidence of spinal hematoma in obstetric patients between 0 and 0.6 per 100,000 epidural catheterizations [
         <a href="#rid44">
          44,58-61
         </a>
         ]. As an example, an analysis of data from the Nationwide Inpatient Sample found 15 epidural hematomas among over 2,300,000 obstetric epidural catheterizations, for an incidence of 0.6 per 100,000 [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication", section on 'Incidence and risk factors for SEH after neuraxial anesthesia'
         </a>
         .)
        </p>
        <p>
         SEH is less likely with a single-shot spinal technique due to the relatively small size of the spinal needle [
         <a href="#rid62">
          62
         </a>
         ] and the lack of an indwelling catheter. (See
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication", section on 'Spinal epidural hematoma (SEH)'
         </a>
         .)
        </p>
        <p>
         The diagnosis of SEH is complicated by the concealed nature of the bleeding; thus, a high index of suspicion must be maintained. The most common presenting symptoms of neurologically significant SEH are progressive motor and sensory block, and bowel or bladder dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication", section on 'Typical presentation'
         </a>
         .)
        </p>
        <p>
         Back pain occurs in only 25 percent of cases. Low-dose neuraxial techniques for labor analgesia produce minimal motor block and facilitate continuous monitoring of lower extremity function in patients at risk for development of neuraxial hematoma. Evaluation and management of suspected SEH are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication", section on 'Evaluation, management, and prognosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H51358722">
         <span class="h3">
          Neuraxial analgesia and the anticoagulated patient
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pregnant women may be treated with anticoagulants for a variety of indications, including thrombophilia or history of venous thrombosis or thromboembolism. The risk of hemorrhage into the neuraxis is increased in anticoagulated patients; thus, one must consider the type of anticoagulant used, the dose, and the timing of its administration. (See
         <a class="medical medical_review" href="/z/d/html/1342.html" rel="external">
          "Use of anticoagulants during pregnancy and postpartum"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3627956713">
         <span class="h3">
          Neuraxial analgesia and low platelets
         </span>
         <span class="headingEndMark">
          —
         </span>
         A low platelet count or deficient platelet function predispose to SEH upon neuraxial instrumentation. The precise platelet count needed to safely perform neuraxial analgesia is unknown [
         <a href="#rid63">
          63
         </a>
         ], because epidural hematoma is so rare in parturients. Estimates of risk are based on reported neuraxial techniques in parturients with thrombocytopenia. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A review of 1525 reported neuraxial techniques performed in parturients with thrombocytopenia found no cases of epidural hematoma, as indicated by the need for decompressive laminectomy [
         <a href="#rid64">
          64
         </a>
         ]. The upper bounds of the 95 percent confidence intervals for the incidence of epidural hematoma were 11 percent for a platelet count &lt;49,000/microL, 3 percent for a platelet count of 50,000 to 69,000/microL, and 0.2 percent for a platelet count 70,000 to 100,000/microL, based solely on the number of patients in each group.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a subsequent single center review of 308 parturients who had neuraxial block with a platelet count &lt;100,000/microL, there were no SEHs [
         <a href="#rid65">
          65
         </a>
         ]. It is difficult to draw a conclusion for those parturients with platelet count below 70,000/microL, because neuraxial block was avoided in the majority of these parturients. When the authors analyzed this data along with the data from the study above, the upper bounds of the 95% confidence interval for the incidence of epidural hematoma with a platelet count 70,000 to 100,000 was 0.19 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a meta-analysis of 131 case reports/series, retrospective and prospective observational studies involving various different populations of thrombocytopenic patients (7476 procedures) who underwent lumbar neuraxial procedures, there were four reported cases of SEH in obstetric patients with platelet counts between 76,000 and 91,000 x 10
         <sup>
          6
         </sup>
         /L [
         <a href="#rid66">
          66
         </a>
         ]. These patients had risk factors other than thrombocytopenia, or had either preeclampsia or hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.
        </p>
        <p>
        </p>
        <p>
         The threshold platelet count for performing neuraxial techniques varies among clinicians, and should be individualized based on patient factors, including the specific patient's risks associated with general anesthesia should it become necessary. Our approach is consistent with a 2021 consensus statement from the Society for Obstetric Anesthesia and Perinatology (SOAP) [
         <a href="#rid67">
          67
         </a>
         ], which is shown in an algorithm  (
         <a class="graphic graphic_algorithm graphicRef131451" href="/z/d/graphic/131451.html" rel="external">
          algorithm 1
         </a>
         ). We typically avoid neuraxial anesthesia in thrombocytopenic patients with a history of bleeding associated with thrombocytopenia or current signs of coagulopathy (eg, bleeding from intravenous catheter sites or mucous membranes). We perform neuraxial anesthesia techniques in patients without a bleeding history with stable platelet counts above 70,000/microL. For patients with platelet counts 50,000 to 70,000/microL, we perform neuraxial anesthesia if there is compelling reason to do so after risk-benefit analysis [
         <a href="#rid68">
          68
         </a>
         ], and prefer a spinal rather than an epidural technique (see
         <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">
          "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"
         </a>
         ). We avoid neuraxial techniques in patients with platelet counts below 50,000/microL.
        </p>
        <p>
         The rate of decline of the platelet count should be considered when deciding when or whether to perform neuraxial techniques. The platelet count may decline precipitously in patients with HELLP syndrome. In these patients, the platelet count should be measured within six hours of performing a neuraxial block or removing a neuraxial catheter, and compared with previous counts.
        </p>
        <p>
         It is not necessary to routinely obtain a platelet count before administration of regional anesthesia in parturients with no history or clinical evidence of a coagulation disorder (bleeding, bruising). (See
         <a class="medical medical_review" href="/z/d/html/1315.html" rel="external">
          "Preoperative assessment of bleeding risk"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2023046439">
         <span class="h2">
          Respiratory depression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Respiratory depression is a risk when opioids are administered by any route, including neuraxial injection. Clinically significant respiratory depression after neuraxial opioids is rare at usual doses; risk is increased by prior or concomitant administration of systemic opioids. (See
         <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">
          "Post-cesarean delivery analgesia", section on 'Side effects and complications'
         </a>
         .)
        </p>
        <p>
         The time course of neuraxial opioid induced respiratory depression depends on the lipid solubility of the drug.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After neuraxial bolus administration of a lipophilic opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         ) respiratory depression, if it occurs, would be expected within approximately two hours [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory depression after neuraxial administration of hydrophilic opioid (eg,
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         ) is delayed, and may not occur until 12 hours or more after injection, when a patient is usually on a postpartum floor without intensive monitoring. Thus, a protocol should be in place for postpartum care including respiratory monitoring for all patients who receive neuraxial opioids for postoperative pain control.
        </p>
        <p>
        </p>
        <p>
         Respiratory depression after neuraxial hydrophilic opioids is much less common in parturients than in other patient populations. SOAP published a consensus statement on monitoring following administration of neuraxial
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         for cesarean delivery analgesia, stratified based on the dose of neuraxial opioid and patient risk factors [
         <a href="#rid69">
          69
         </a>
         ].  (
         <a class="graphic graphic_algorithm graphicRef126139" href="/z/d/graphic/126139.html" rel="external">
          algorithm 2
         </a>
         ) These issues are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">
          "Post-cesarean delivery analgesia", section on 'Side effects and complications'
         </a>
         .)
        </p>
        <p>
         Neuraxial opioid induced respiratory depression is treated with intravenous administration of an opioid antagonist (eg,
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         ). The dose should be titrated to effect (40 to 80 mcg IV increments), followed by an infusion at a dose sufficient to maintain an adequate respiratory rate until the effect of the opioid has dissipated (eg, 1 to 2 mcg/kg/minute) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3016018035">
         <span class="h2">
          Backache
         </span>
         <span class="headingEndMark">
          —
         </span>
         Localized back pain related to tissue trauma at the site of a neuraxial procedure may be present for several days, but prospective studies have consistently reported no correlation between neuraxial analgesia and long term back ache [
         <a href="#rid71">
          71-77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1979800505">
         <span class="h2">
          Postpartum neuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neurologic complications associated with neuraxial anesthesia are extremely rare. Neurologic injury can be the result of needle or catheter trauma, drug toxicity, SEH, or infection, and may involve injury to the spinal cord, nerve roots, or neuraxial vasculature. The incidence of most neurologic complications has not been determined because they are so rare. Neurologic complications of obstetric anesthesia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/115387.html" rel="external">
          "Serious neurologic complications of neuraxial anesthesia procedures in obstetric patients"
         </a>
         .)
        </p>
        <p>
         Postpartum neuropathies usually have obstetric etiologies, and are often due to compression of nerves of the lumbosacral plexus by the descending fetal head, extrinsic neural compression (eg, by stirrup supports) or from ischemia due to prolonged stretching of nerves (eg, extreme hip flexion) during the second stage of labor. (See
         <a class="medical medical_review" href="/z/d/html/127985.html" rel="external">
          "Overview of the postpartum period: Disorders and complications", section on 'Neuropathy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H109094585">
         <span class="h2">
          Severe infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidural abscess and meningitis are uncommon but potentially catastrophic complications of neuraxial anesthesia procedures. Epidural abscess is more likely to occur after epidural techniques, particularly after prolonged epidural catheterization, whereas meningitis typically occurs after the dura has been punctured, either intentionally as part of a spinal anesthetic or unintentionally as a complication of an epidural procedure. Spinal epidural abscess is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/115387.html" rel="external">
          "Serious neurologic complications of neuraxial anesthesia procedures in obstetric patients", section on 'Meningitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115387.html" rel="external">
          "Serious neurologic complications of neuraxial anesthesia procedures in obstetric patients", section on 'Spinal epidural abscess'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2301179188">
         <span class="h1">
          FETAL EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuraxial analgesia can affect the fetus directly by placental transfer of local anesthetic or opioids, or indirectly via maternal effects (ie, hypotension or uterine hypertonus). (See
         <a class="local">
          'Effects on the neonate'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2294090447">
         <span class="h2">
          Placental perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         The placental bed is not autoregulated and, therefore, its perfusion is entirely dependent upon maternal blood pressure. Hypotension caused by neuraxial block can result in decreased fetal oxygenation and a deterioration in the fetal heart rate pattern (eg, bradycardia, repetitive late decelerations). (See
         <a class="medical medical_review" href="/z/d/html/418.html" rel="external">
          "Intrapartum fetal heart rate monitoring: Overview", section on 'Physiologic significance of selected FHR characteristics'
         </a>
         .)
        </p>
        <p>
         However, in the absence of hypotension, epidural local anesthetics have been shown to improve intervillous blood flow [
         <a href="#rid78">
          78
         </a>
         ], to have minimal effect on uterine or fetal umbilical vasculature as assessed by Doppler velocimetry [
         <a href="#rid79">
          79,80
         </a>
         ], and to be associated with improved neonatal acid–base status [
         <a href="#rid38">
          38,81
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1936778416">
         <span class="h2">
          Fetal bradycardia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initiation of neuraxial analgesia may be followed by fetal heart rate abnormalities (eg, bradycardia, reduced variability, late decelerations) as a result of hypotension, uterine hyperactivity, or increased uterine tone. In the absence of hypotension, transient fetal heart rate abnormalities in this setting presumably relate to a reduction in maternal circulating
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         after rapid onset of analgesia, and loss of epinephrine's beta-sympathomimetic relaxant effects on the myometrium [
         <a href="#rid82">
          82,83
         </a>
         ]. The resulting uterine hypertonus can compromise placental blood flow. Fetal bradycardia after rapid onset of analgesia usually occurs within the first 15 minutes, and when treated with usual measures, does not result in fetal acidemia, low Apgar scores, or the need for cesarean delivery [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         If fetal bradycardia occurs after initiation of neuraxial analgesia, treatment should include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Discontinue intravenous
         <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">
          oxytocin
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place the parturient in the lateral decubitus position to relieve aortocaval compression
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Administer supplemental oxygen
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Correct hypotension
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fetal scalp stimulation (if accessible)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For persistent uterine hypertonus or tachysystole, administer tocolytic medication (eg,
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         60 to 90 mcg intravenously repeated in two to three minutes, if necessary, followed by
         <a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">
          terbutaline
         </a>
         250 mcg subcutaneously if there is no response to nitroglycerin) (see
         <a class="medical medical_review" href="/z/d/html/4476.html" rel="external">
          "Induction of labor with oxytocin", section on 'Tachysystole'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Most studies have reported that fetal bradycardia is more common after intrathecal opioid administration, usually as part of combined spinal-epidural analgesia, than after initiation of epidural analgesia. A 2020 meta-analysis of randomized trials reported an increased risk of fetal bradycardia for combined spinal-epidural (CSE) compared with standard epidural labor analgesia (ELA) technique (RR 2.38, CI 1.57-3.62) [
         <a href="#rid5">
          5
         </a>
         ]. Rates of cesarean delivery and apgar scores at 1 and 5 minutes were similar.
        </p>
        <p class="headingAnchor" id="H100840725">
         <span class="h1">
          EFFECTS ON THE PROGRESS AND OUTCOME OF LABOR
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obstetric anesthesia practice has evolved with the goal of reducing or eliminating deleterious effects on the progress or outcome of labor and delivery.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing of neuraxial analgesia
         </strong>
         –
         <strong>
         </strong>
         The timing of administration of neuraxial analgesia (early versus later in labor) has been shown to have no effect on the rate of cesarean delivery or other obstetric outcomes. A 2014 meta-analysis of nine studies including over 15,000 patients that compared early initiation (&lt;4 cm cervical dilatation) with later initiation of neuraxial analgesia reported no difference in cesarean delivery rate, instrumental delivery, duration of second stage of labor, or fetal outcomes [
         <a href="#rid84">
          84
         </a>
         ]. Thus, epidural analgesia should be administered on request for patients who are clearly in labor, without waiting for a specific degree of cervical dilation [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cesarean delivery
         </strong>
         –
         <strong>
         </strong>
         Multiple randomized trials have shown that neuraxial analgesia does not increase the risk of cesarean delivery. A 2018 meta-analysis of 40 randomized trials that compared neuraxial analgesia with non-neuraxial analgesia or no analgesia reported that epidural analgesia did not significantly increase the risk of cesarean delivery (relative risk 1.07, 95% CI 0.96-1.08) [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Instrumental delivery
         </strong>
         –
         <strong>
         </strong>
         Neuraxial analgesia using high concentrations of local anesthetic (LA) may increase the risk of instrumental delivery. However, standard obstetric anesthesia practice now involves the use of low concentration LA/opioid solutions for labor analgesia, partly to minimize the degree of motor block, and to preserve the ability to push during the second stage of labor. (See
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Goals for neuraxial drug choice'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A 2013 meta-analysis of randomized controlled trials that compared low concentration epidural LA for labor (eg, ≤0.1%
         <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">
          bupivacaine
         </a>
         or ≤0.17%
         <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">
          ropivacaine
         </a>
         ) with higher concentration solutions found a reduced risk of instrumental delivery with the use of low concentration LAs (odds ratio [OR] = 0.70; 95% CI 0.56 to 0.86) [
         <a href="#rid86">
          86
         </a>
         ]. Similarly, a 2017 meta-analysis of studies using only dilute epidural LA found no difference in the instrumental delivery rate between patients who had epidural analgesia, and those who did not [
         <a href="#rid87">
          87
         </a>
         ]. A 2018 meta-analysis of randomized trials that compared epidural with non-epidural analgesia or no analgesia for labor reported no difference in instrumental delivery rate in trials conducted after 2005 [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Emergency delivery for fetal compromise
         </strong>
         –
         <strong>
         </strong>
         In contrast with studies that have found no effect of neuraxial analgesia on the incidence of cesarean or instrumental delivery in contemporary practice, two studies [
         <a href="#rid88">
          88,89
         </a>
         ] have found an association between neuraxial analgesia and emergency delivery for presumed fetal compromise. However, it is important to point out that association does not imply causation. Furthermore, the quality of the existing evidence is insufficient to recommend avoiding neuraxial analgesia for patients at high risk of cesarean delivery. In fact one of the indications for early labor epidural placement is to reduce the need for general anesthesia in the event of an unplanned cesarean delivery, particularly in high risk parturients. (See
         <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">
          "Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Preparation for surgical anesthesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Examples of relevant studies include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the meta-analysis of randomized trials described above, the incidence of cesarean delivery for fetal distress was similar in patients who had epidural analgesia, compared with those who had systemic opioid analgesia (13 trials, 6750 patients; 3.3 versus 2.3 percent, relative risk [RR] 1.32, 95% CI 0.97–1.79) [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a retrospective perinatal database study of approximately 630,000 singleton deliveries between 2014 and 2018 in the Netherlands, epidural labor analgesia was associated with increased risk of emergency delivery (cesarean or instrumental) compared with alternative analgesia (13.2 versus 7.0 percent, RR 1.72, 95% CI 1.67–1.77) [
         <a href="#rid88">
          88
         </a>
         ]. Conclusions are limited by the very high rate of emergency delivery, the very low neuraxial analgesia rate (31 percent in nulliparous patients, 10 percent in parous patients), and higher incidence of comorbidities in patients who had epidural analgesia. In addition, there was lack of information on epidural or hemodynamic management or the indication for placing an epidural, which was potentially more likely in a patient with a poor fetal heart rate tracing.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Another study was a post hoc analysis of per protocol data from a randomized trial that compared epidural analgesia with intravenous
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         patient controlled analgesia (PCA) for 619 singleton deliveries in the Netherlands from 2011 and 2012 [
         <a href="#rid89">
          89
         </a>
         ]. The incidence of emergency delivery for presumed fetal compromise was higher in patients who received epidural analgesia (14.8 versus 8.3 percent, odds ratio 1.69, 95% CI 1.01–2.83). Conclusions are limited by the very high emergency delivery rate, and lack of information on the management of labor, or drugs used for epidural analgesia, and the incidence of hypotension after epidural analgesia. Epidural management is of particular concern because almost half of the patients originally randomized to epidural analgesia were excluded from this post hoc analysis because they had no pain relief.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration of labor
         </strong>
         – Neuraxial analgesia may decrease the duration of the first stage of labor, and may prolong the second stage of labor to a variable degree.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          First stage of labor
         </strong>
         –
         <strong>
         </strong>
         A number of prospective randomized trials that compared epidural [
         <a href="#rid90">
          90-92
         </a>
         ] or intrathecal [
         <a href="#rid93">
          93
         </a>
         ] analgesia with systemic opioid analgesia for labor have reported shorter labor after early administration of neuraxial analgesia. As an example, in one trial, 750 nulliparous women were randomly assigned to receive intrathecal
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or systemic
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         at first request for analgesia [
         <a href="#rid93">
          93
         </a>
         ]. The median time from initiation of analgesia to full cervical dilation was significantly shorter after neuraxial analgesia (295 minutes versus 385 minutes).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Second stage of labor
         </strong>
         –
         <strong>
         </strong>
         The effect of neuraxial analgesia on the second stage of labor, and the clinical relevance of reported effects, are unclear, partly because the start of second stage (complete cervical dilation) is difficult to measure and depends on the timing of a cervical examination, rather than a defined obstetrical event. Retrospective reviews have reported an association between epidural analgesia and a longer second stage of labor. A multicenter retrospective study including approximately 62,400 nulliparous patients who delivered between 2002 and 2008 reported that the 95
         <sup>
          th
         </sup>
         percentile in the duration of the second stage of labor was approximately 50 minutes longer in patients who had epidural analgesia than those who did not (3.6 versus 2.8 hours) [
         <a href="#rid94">
          94
         </a>
         ]. In another retrospective review of labor in 22,370 nulliparous women between 1976 and 2008, epidural analgesia use prolonged 95
         <sup>
          th
         </sup>
         percentile duration of the second stage of labor by 2 hours and 19 minutes (197 minutes without epidural versus 336 minutes with epidural) [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Randomized trials have reported a much smaller effect of epidural analgesia on the duration of the second stage of labor [
         <a href="#rid87">
          87
         </a>
         ]. In addition, the use of low concentration epidural LA solutions (which is the current standard of care) may minimize prolongation of the second stage of labor, compared with higher concentrations. A 2011 meta-analysis of studies of neuraxial labor analgesia (with mixed low and higher concentration LAs) reported a mean increase of 13.66 minutes in the second stage of labor with the use of neuraxial analgesia [
         <a href="#rid38">
          38
         </a>
         ], whereas a 2017 meta-analysis (exclusively low concentration LAs) reported a statistically insignificant mean increase of 5.7 minutes [
         <a href="#rid87">
          87
         </a>
         ]. Similarly, meta-analysis of studies that compared higher concentration epidural LA with dilute LA solutions found a shorter second stage of labor (weighted mean difference -14 minutes) with the use of dilute solutions [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1165903124">
         <span class="h1">
          EFFECTS ON BREASTFEEDING
         </span>
         <span class="headingEndMark">
          —
         </span>
         The effects of neuraxial analgesia on breastfeeding are controversial and difficult to study, and existing literature is insufficient to make recommendations on this issue. Studies of the effects of labor analgesia on breastfeeding have reported conflicting results, and have included heterogeneous patient populations and labor analgesia techniques, and differing methods for evaluating breastfeeding [
         <a href="#rid85">
          85,96-101
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Multiple patient factors affect the likelihood that a patient will breast feed in the postpartum period and long term. Compared with systemic opioids for labor analgesia, neuraxial techniques result in lower or negligible fetal opioid levels, and would therefore be expected to interfere less with neonatal feeding behaviors.
        </p>
        <p>
         A randomized trial including approximately 950 parturients reported no difference in the breastfeeding rate at six weeks or three months among those who received labor analgesia with epidural
         <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">
          bupivacaine
         </a>
         with or without
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         1 mcg/mL or 2 mcg/mL [
         <a href="#rid99">
          99
         </a>
         ]. The patients in this trial were multiparous, had previously breastfed an infant, and planned to breastfeed for more than three months; results may not apply to other patient populations.
        </p>
        <p class="headingAnchor" id="H1879592722">
         <span class="h1">
          EFFECTS ON THE NEONATE
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the absence of maternal hypotension prior to delivery, neuraxial analgesia and anesthesia do not negatively affect the neonate. (See
         <a class="local">
          'Hypotension'
         </a>
         above and
         <a class="local">
          'Placental perfusion'
         </a>
         above.)
        </p>
        <p>
         Opioids administered systemically or epidurally rapidly enter the maternal circulation, cross the placenta, and equilibrate with fetal circulation [
         <a href="#rid102">
          102
         </a>
         ]. However, with the low concentrations of lipophilic opioids (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         and
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         ) used for labor analgesia, even prolonged epidural opioid infusion rarely causes fetal accumulation, neonatal respiratory depression, or reduced neonatal behavioral scores [
         <a href="#rid102">
          102-105
         </a>
         ]. Similarly, with the dilute concentrations of local anesthetics used for labor, minimal placental drug transfer and neonatal accumulation occur [
         <a href="#rid102">
          102
         </a>
         ]. Neurobehavioral studies in neonates whose mothers received epidural analgesia or systemic opioids have shown either no difference [
         <a href="#rid106">
          106
         </a>
         ] or improved scores in neonates of mothers receiving epidurals [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
         A meta-analysis of 10 randomized trials reported that neonates of mothers who received epidural analgesia had fewer Apgar scores below seven and required
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         less often than those whose mothers received systemic opioids [
         <a href="#rid108">
          108
         </a>
         ]. In contrast, in a retrospective study of over 2200 neonates whose mothers received neuraxial labor analgesia with
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         , there was a dose dependent increase in positive neonatal toxicology testing for fentanyl [
         <a href="#rid109">
          109
         </a>
         ]. Over 90 percent of infants whose mothers received &gt;200 mcg neuraxial fentanyl tested positive. Five minute Apgar scores &lt;7 were more likely in infants who tested positive, though other neonatal outcomes (eg, need for resuscitation, neonatal ICU admission) were similar in neonates who tested positive compared with those who tested negative.
        </p>
        <p>
         Epidural
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         is routinely administered as an adjunct to local anesthetics during epidural anesthesia for cesarean delivery, to improve intraoperative analgesia (see
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Epidural drugs for CD'
         </a>
         ). Many clinicians wait until the umbilical cord is clamped to administer fentanyl, to avoid any risk of fetal transfer. However, many studies have reported no effects on neonatal outcomes (eg, Apgar scores, umbilical blood gases, neonatal behavioral tests) with administration of 50 to 100 mcg of epidural fentanyl during initiation of epidural anesthesia, prior to cord clamp [
         <a href="#rid110">
          110-112
         </a>
         ]. Epidural
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         is routinely administered for postoperative pain relief, after the umbilical cord is clamped, and therefore has no effect on the neonate.
        </p>
        <p>
         The doses of opioid used for intrathecal administration are considerably lower than epidural doses, and maternal systemic uptake is negligible, such that direct fetal or neonatal effects are unlikely to occur.
        </p>
        <p class="headingAnchor" id="H3044005400">
         <span class="h1">
          EPIDURAL ANALGESIA AND CHILDHOOD AUTISM
         </span>
         <span class="headingEndMark">
          —
         </span>
         After review of available data, we believe that there is no convincing evidence that labor epidurals cause autism spectrum disorder (ASD) or other types of behavioral or learning disabilities in the parturient's infant, and no evidence that choosing another form of pain relief for labor, or no pain relief, reduces the risk of autism or other disabilities.
        </p>
        <p>
         Relevant evidence consists of retrospective observational or database studies, and results are mixed. Given the retrospective nature of the data, confounding is possible and causation cannot be determined. In studies that have shown an association between epidural analgesia and offspring risk of ASD, that association usually disappears or becomes weak when adjusting for confounders [
         <a href="#rid113">
          113-123
         </a>
         ]. In a meta-analysis of six observational studies including over 3.3 million parturients, neuraxial labor analgesia was associated with a small increase in the risk of ASD in offspring (adjusted hazard ratio 1.07, 95% CI 1.04 -1.10) [
         <a href="#rid124">
          124
         </a>
         ]. The association was very weak, and the evidence was judged to be of very low quality, primarily due to high risk of bias and inconsistency. This association disappeared when studies with a high risk of bias and studies that accounted for unmeasured familial factors such as socioeconomic and genetic factors were excluded.
        </p>
        <p>
         Examples of studies of the association between neuraxial analgesia and childhood ASD are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a United States insurance database cohort study including &gt;1.6 million patients who had vaginal deliveries, exposure to maternal neuraxial labor analgesia was associated with a slightly increased risk of ASD by age 10 years in offspring, compared with unexposed offspring (adjusted hazard ratio 1.07, 95% CI 1.00-1.14) [
         <a href="#rid120">
          120
         </a>
         ]. A meta-analysis of data from this study and three others (&gt;2,470,000 patients) found a pooled adjusted hazard ratio of 1.10, 95% CI 1.06-1.13 [
         <a href="#rid120">
          120
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective case control study of 465 children with ASD, 481 siblings of those children, and 1313 controls, the rate of epidural use during labor was higher in mothers who delivered children who were later diagnosed with ASD [
         <a href="#rid113">
          113
         </a>
         ]. However, the rate of obstetric complications was also higher in mothers of children with ASD, and the reasons for epidural placement (eg, obstetric complications, pain relief) were not available, raising the possibility that the association between epidural use and ASD was due to complications for which the epidural was placed. The rate of epidural use during delivery of siblings without ASD was similar to the rate of epidural use in for delivery of children with ASD, supporting a lack of a causative relationship between epidurals and ASD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A large retrospective longitudinal birth cohort database study published in 2020 reported an association between labor epidural analgesia (LEA) in parturients and the diagnosis of autism in their children [
         <a href="#rid114">
          114
         </a>
         ]. Among approximately 148,000 women who delivered vaginally, ASD was diagnosed in 1.9 percent of children of mothers who received LEA, compared with 1.3 percent of children in the non-LEA group (adjusted hazard ratio 1.37, 95% CI 1.23-1.53). However, like all observational studies, a causal relationship between LEA and autism was not established. There were significant methodologic problems with this study; there were numerous demographic differences between the cohort of patients who received LEA and those who did not, including factors that have been associated with an increased risk of autism. In addition, potentially important details about the course of labor and delivery and other possible causes of autism were not provided. Since the etiology of autism is unknown, even after controlling for known risk factors, there remains the possibility that the association between LEA and autism was due to unknown confounders.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In response to publication of this study, five major obstetric and anesthesia societies (Society for Obstetric Anesthesia and Perinatology, American Society of Anesthesiologists, Society for Pediatric Anesthesia, American College of Obstetrics and Gynecology, and the Society for Maternal-Fetal Medicine) issued a
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fsoap.memberclicks.net%2Fassets%2Fdocs%2FJAMAPeds_Epidurals_SOAP_ASA_SPA_ACOG_SMFM_Media_Response_101220.pdf&amp;token=CEUflUuWRnDCTyJUT8Y7YrkTIINTJe48aD5rODNFscMXnojNRWbuffAfnDr3KZ8Ql9yJrV02iIsyc28VAYyi3uMTIqqniiDy2fnrkqC6Kmqh4eGy1IionG8MF3LPJJen%2FCuzg4EDdgs592WadSyKUA%3D%3D&amp;TOPIC_ID=4469" target="_blank">
          joint statement
         </a>
         that this study does not provide credible evidence that LEA causes autism. Other anesthesia and obstetric professional societies in Canada [
         <a href="#rid115">
          115
         </a>
         ] and the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Frcoa.ac.uk%2Fnews%2Fno-evidence-labour-epidurals-cause-autism&amp;token=der0mlvPkMyxWTlhP0%2BMf2N4S9%2B3h60srTrljoguSCHNLhMCCKZ1g46gLlQIkVpSLLfze3VaXE%2FYmsAafTThqQe%2FMeOwU9faiI8S6qgUxYA%3D&amp;TOPIC_ID=4469" target="_blank">
          United Kingdom
         </a>
         have also issued statements on the methodologic problems of the study and lack of evidence that labor epidurals cause autism.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A large population-based cohort study of over 123,000 vaginal singleton births in Manitoba, Canada from 2005 to 2016 used information from four statewide databases to evaluate the association between exposure to maternal epidural labor analgesia (ELA) and autism diagnosed after the age of 18 months in offspring [
         <a href="#rid116">
          116
         </a>
         ]. After adjusting for maternal sociodemographic, pregnancy-related and preexisting factors, and birth-specific factors, there was no association between ELA exposure and increased risk of autism in offspring (adjusted hazard ratio 1.08 (95% CI 0.78-1.22).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another Canadian administrative database study of &gt;650,000 vaginal births, there was a small increase in the risk of autism diagnosed in childhood in offspring of patients who had intrapartum epidural analgesia (adjusted HR 1.14 (95% CI 1.08–1.21) [
         <a href="#rid122">
          122
         </a>
         ]. The authors acknowledged that these findings were insufficient to demonstrate causation and results must be interpreted with caution given the methodological limitations inherent in observational studies.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          ALLERGIC REACTION TO LOCAL ANESTHETIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         Allergic reactions to local anesthetics (LAs) are very rare. Most allergic reactions are delayed-type, cell mediated reactions (delayed local swelling or contact dermatitis), which are rarely dangerous. They occur more commonly with ester LAs (eg, 2-choloroprocaine,
         <a class="drug drug_general" data-topicid="10278" href="/z/d/drug information/10278.html" rel="external">
          tetracaine
         </a>
         ) than with amide LAs (eg,
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">
          bupivacaine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">
          ropivacaine
         </a>
         ). Serious IgE-mediated reactions can also occur, including life-threatening anaphylaxis. Patients who describe symptoms suggestive of this type of reaction should be referred to an allergist if possible  (
         <a class="graphic graphic_table graphicRef100732" href="/z/d/graphic/100732.html" rel="external">
          table 1
         </a>
         ). Skin testing and graded challenge can determine which specific drugs the patient can safely receive. Allergic reactions to LAs are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">
          "Allergic reactions to local anesthetics"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3296700067">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/120196.html" rel="external">
          "Society guideline links: Post dural puncture headache"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/131710.html" rel="external">
          "Society guideline links: Obstetric anesthesia"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/129632.html" rel="external">
          "Society guideline links: Local and regional anesthesia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H364269288">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/16908.html" rel="external">
          "Patient education: Managing pain during labor and childbirth (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H37">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Side effects
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypotension may occur primarily as a result of the sympathetic blockade associated with neuraxial block, and is more common during anesthesia for cesarean delivery than during labor analgesia. For prevention of neuraxial anesthesia-induced hypotension during cesarean delivery, for most patients we suggest prophylactic administration of a vasopressor along with intravenous crystalloid coloading (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We administer a low-dose
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         infusion (ie, starting at 50 mcg/min) with phenylephrine rescue boluses, along with a rapid bolus of intravenous crystalloid (500 to 1000 mL), at the time of induction or neuraxial anesthesia placement, aiming for maternal blood pressure close to baseline. The patient is typically positioned with left uterine displacement to prevent aortocaval compression. (See
         <a class="local">
          'Hypotension'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pruritus is a common side effect of neuraxial opioids, and is treated most effectively with administration of a small dose of opioid antagonist (eg,
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         [40 to 80 mcg intravenously]),
         <a class="drug drug_general" data-topicid="9679" href="/z/d/drug information/9679.html" rel="external">
          naltrexone
         </a>
         (6 mg orally), or the mixed opioid agonist-antagonist
         <a class="drug drug_general" data-topicid="9676" href="/z/d/drug information/9676.html" rel="external">
          nalbuphine
         </a>
         (2.5 to 5 mg intravenously [IV]). (See
         <a class="local">
          'Pruritus'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intrapartum fever, nausea and vomiting, urinary retention, and shivering are other possible side effects of neuraxial analgesia or anesthesia. (See
         <a class="local">
          'Side effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pregnant patients are at higher risk of post dural puncture headache (PDPH) than other patients. Severe PDPH is usually treated with an epidural blood patch (EBP). (See
         <a class="local">
          'Post dural puncture headache'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Local anesthetic systemic toxicity (LAST) is a rare but potentially lethal complication of epidural administration of local anesthetics. Pregnant patients are at increased risk for LAST when high doses of a high concentration local anesthetic are administered. (See
         <a class="local">
          'Local anesthetic systemic toxicity'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inadequate analgesia, motor block, and high neuraxial block are complications that can be minimized by management techniques and choice of neuraxial drugs. (See
         <a class="local">
          'Inadequate anesthesia'
         </a>
         above and
         <a class="local">
          'Motor block'
         </a>
         above and
         <a class="local">
          'Post dural puncture headache'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spinal epidural hematoma (SEH) is a rare, potentially devastating complication of neuraxial anesthesia techniques, that is more common in patients who are coagulopathic, either because of anticoagulant medication, systemic disease, or thrombocytopenia. For patients with thrombocytopenia, we perform neuraxial anesthesia in patients without a bleeding history with stable platelet counts above 70,000/microL. For patients with platelet counts 50,000 to 70,000/microL, we perform neuraxial anesthesia if there is compelling reason to do so after risk-benefit analysis, and prefer a spinal rather than an epidural technique  (
         <a class="graphic graphic_algorithm graphicRef131451" href="/z/d/graphic/131451.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Spinal epidural hematoma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Postpartum neuropathies usually have obstetric causes. Very rarely, neurologic complications can be the result of needle or catheter trauma, drug toxicity, SEH, or infection, related to neuraxial anesthesia techniques. (See
         <a class="local">
          'Postpartum neuropathy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Strict aseptic technique should be followed during neuraxial anesthesia techniques, to reduce the risk of meningitis and epidural abscess, which are rare, serious complications. (See
         <a class="local">
          'Severe infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fetal effects
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neuraxial analgesia can affect the fetus directly by placental transfer of local anesthetic or opioids, or indirectly via maternal effects (ie, hypotension or uterine hypertonus). Placental transfer of drugs is rare with low-dose epidural or spinal drug administration. (See
         <a class="local">
          'Placental perfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the absence of hypotension, fetal bradycardia may occur with abrupt onset of analgesia, and is more common after intrathecal opioid administration for labor analgesia than after initiation of epidural analgesia. Fetal bradycardia in this setting is typically transient, and when treated with usual measures, does not increase the risk of cesarean delivery or adverse neonatal outcomes. (See
         <a class="local">
          'Fetal bradycardia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effects on the progress and outcome of labor
         </strong>
         – Low dose neuraxial labor analgesia techniques administered at any time during labor do not increase the risk of cesarean delivery or instrumental delivery. Neuraxial analgesia may shorten the first stage of labor, and may prolong the second stage of labor to a variable degree. (See
         <a class="local">
          'Effects on the progress and outcome of labor'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Breastfeeding
         </strong>
         – Neuraxial labor analgesia is unlikely to affect breastfeeding, though existing literature is insufficient to confirm this conclusion. (See
         <a class="local">
          'Effects on breastfeeding'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal effects
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the absence of maternal hypotension prior to delivery, neuraxial analgesia and anesthesia do not negatively affect the neonate. (See
         <a class="local">
          'Effects on the neonate'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         There is no convincing evidence that epidural labor analgesia (ELA) causes autism, or that choosing another form of pain relief for labor or no pain relief reduces the risk of autism or other disabilities. (See
         <a class="local">
          'Epidural analgesia and childhood autism'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Morgan PJ, Halpern SH, Tarshis J. The effects of an increase of central blood volume before spinal anesthesia for cesarean delivery: a qualitative systematic review. Anesth Analg 2001; 92:997.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grant GJ, Susser L, Cascio M, et al. Hemodynamic effects of intrathecal fentanyl in nonlaboring term parturients. J Clin Anesth 1996; 8:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmer CM, Van Maren G, Nogami WM, Alves D. Bupivacaine augments intrathecal fentanyl for labor analgesia. Anesthesiology 1999; 91:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simmons SW, Taghizadeh N, Dennis AT, et al. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev 2012; 10:CD003401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grangier L, Martinez de Tejada B, Savoldelli GL, et al. Adverse side effects and route of administration of opioids in combined spinal-epidural analgesia for labour: a meta-analysis of randomised trials. Int J Obstet Anesth 2020; 41:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinsella SM, Pirlet M, Mills MS, et al. Randomized study of intravenous fluid preload before epidural analgesia during labour. Br J Anaesth 2000; 85:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimitriou V, Voyagis GS. Opioid-induced pruritus: repeated vs single dose ondansetron administration in preventing pruritus after intrathecal morphine. Br J Anaesth 1999; 83:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh HM, Chen LK, Lin CJ, et al. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg 2000; 91:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wells J, Paech MJ, Evans SF. Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron. Int J Obstet Anesth 2004; 13:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asokumar B, Newman LM, McCarthy RJ, et al. Intrathecal bupivacaine reduces pruritus and prolongs duration of fentanyl analgesia during labor: a prospective, randomized controlled trial. Anesth Analg 1998; 87:1309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah MK, Sia AT, Chong JL. The effect of the addition of ropivacaine or bupivacaine upon pruritus induced by intrathecal fentanyl in labour. Anaesthesia 2000; 55:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyons G, Columb M, Hawthorne L, Dresner M. Extradural pain relief in labour: bupivacaine sparing by extradural fentanyl is dose dependent. Br J Anaesth 1997; 78:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CA, Scavone BM, Loffredi M, et al. The dose-response of intrathecal sufentanil added to bupivacaine for labor analgesia. Anesthesiology 2000; 92:1553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herman NL, Choi KC, Affleck PJ, et al. Analgesia, pruritus, and ventilation exhibit a dose-response relationship in parturients receiving intrathecal fentanyl during labor. Anesth Analg 1999; 89:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girgin NK, Gurbet A, Turker G, et al. Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine. J Clin Anesth 2008; 20:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmer CM, Emerson S, Volgoropolous D, Alves D. Dose-response relationship of intrathecal morphine for postcesarean analgesia. Anesthesiology 1999; 90:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh SI, Rehou S, Marmai KL, Jones PM. The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial. Anesth Analg 2013; 117:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ko MC. Neuraxial opioid-induced itch and its pharmacological antagonism. Handb Exp Pharmacol 2015; 226:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller JL, Hagemann TM. Use of pure opioid antagonists for management of opioid-induced pruritus. Am J Health Syst Pharm 2011; 68:1419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jannuzzi RG. Nalbuphine for Treatment of Opioid-induced Pruritus: A Systematic Review of Literature. Clin J Pain 2016; 32:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen SE, Ratner EF, Kreitzman TR, et al. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg 1992; 75:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gan TJ, Ginsberg B, Glass PS, et al. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997; 87:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh PM, Sultan P, O'Carroll J, et al. Pharmacological agents for prevention of pruritus in women undergoing Caesarean delivery with neuraxial morphine: a systematic review and Bayesian network meta-analysis. Br J Anaesth 2023; 131:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kjellberg F, Tramèr MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001; 18:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           George RB, Allen TK, Habib AS. Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis. Anesth Analg 2009; 109:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norris MC, Grieco WM, Borkowski M, et al. Complications of labor analgesia: epidural versus combined spinal epidural techniques. Anesth Analg 1994; 79:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mishriky BM, Habib AS. Impact of data by Fujii and colleagues on the meta-analysis of metoclopramide for antiemetic prophylaxis in women undergoing Caesarean delivery under neuraxial anaesthesia. Br J Anaesth 2012; 109:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mishriky BM, Habib AS. Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. Br J Anaesth 2012; 108:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen TK, Jones CA, Habib AS. Dexamethasone for the prophylaxis of postoperative nausea and vomiting associated with neuraxial morphine administration: a systematic review and meta-analysis. Anesth Analg 2012; 114:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grape S, Usmanova I, Kirkham KR, Albrecht E. Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis. Anaesthesia 2018; 73:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harnett MJ, O'Rourke N, Walsh M, et al. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesth Analg 2007; 105:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sposito JA, Habib AS. Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient. Int J Obstet Anesth 2010; 19:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beatty NC, Arendt KW, Niesen AD, et al. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine. J Clin Anesth 2013; 25:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marroquin B, Feng C, Balofsky A, et al. Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study. Int J Obstet Anesth 2017; 30:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halpern SH, Arellano R, Preston R, et al. Epidural morphine vs hydromorphone in post-caesarean section patients. Can J Anaesth 1996; 43:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuipers PW, Kamphuis ET, van Venrooij GE, et al. Intrathecal opioids and lower urinary tract function: a urodynamic evaluation. Anesthesiology 2004; 100:1497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiniger CF, Wand S, Nadjari M, et al. Post-void residual volume in labor: a prospective study comparing parturients with and without epidural analgesia. Acta Anaesthesiol Scand 2006; 50:1297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anim-Somuah M, Smyth RM, Cyna AM, Cuthbert A. Epidural versus non-epidural or no analgesia for pain management in labour. Cochrane Database Syst Rev 2018; 5:CD000331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson MJ, Macarthur C, Shennan A, COMET Study Group (UK). Urinary catheterization in labour with high-dose vs mobile epidural analgesia: a randomized controlled trial. Br J Anaesth 2009; 102:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sessler DI. Temperature monitoring and perioperative thermoregulation. Anesthesiology 2008; 109:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamontagne C, Lesage S, Villeneuve E, et al. Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial. Can J Anaesth 2019; 66:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan PH, Bogard TD, Owen MD. Incidence and characteristics of failures in obstetric neuraxial analgesia and anesthesia: a retrospective analysis of 19,259 deliveries. Int J Obstet Anesth 2004; 13:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agaram R, Douglas MJ, McTaggart RA, Gunka V. Inadequate pain relief with labor epidurals: a multivariate analysis of associated factors. Int J Obstet Anesth 2009; 18:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelo R, Smiley RM, Riley ET, Segal S. Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2014; 120:1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beckett VA, Knight M, Sharpe P. The CAPS Study: incidence, management and outcomes of cardiac arrest in pregnancy in the UK: a prospective, descriptive study. BJOG 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Almeida SM, Shumaker SD, LeBlanc SK, et al. Incidence of post-dural puncture headache in research volunteers. Headache 2011; 51:1503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi PT, Galinski SE, Takeuchi L, et al. PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies. Can J Anaesth 2003; 50:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thew M, Paech MJ. Management of postdural puncture headache in the obstetric patient. Curr Opin Anaesthesiol 2008; 21:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banks S, Paech M, Gurrin L. An audit of epidural blood patch after accidental dural puncture with a Tuohy needle in obstetric patients. Int J Obstet Anesth 2001; 10:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen LK, Huang CH, Jean WH, et al. Effective epidural blood patch volumes for postdural puncture headache in Taiwanese women. J Formos Med Assoc 2007; 106:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paech MJ, Doherty DA, Christmas T, et al. The volume of blood for epidural blood patch in obstetrics: a randomized, blinded clinical trial. Anesth Analg 2011; 113:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nesbitt C, Amukotuwa S, Chapman C, Batchelor P. Lumbar blood patching for proximal CSF leaks: where does the blood go? BMJ Case Rep 2015; 2015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell, AL. Spenopalatine ganglion block: a simple block in the management of chronic pain. AJPM 1993; 3:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen S, Ramos D, Grubb W, et al. Sphenopalatine ganglion block: a safer alternative to epidural blood patch for postdural puncture headache. Reg Anesth Pain Med 2014; 39:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen S, Levin D, Mellender S, et al. Topical Sphenopalatine Ganglion Block Compared With Epidural Blood Patch for Postdural Puncture Headache Management in Postpartum Patients: A Retrospective Review. Reg Anesth Pain Med 2018; 43:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jespersen MS, Jaeger P, Ægidius KL, et al. Sphenopalatine ganglion block for the treatment of postdural puncture headache: a randomised, blinded, clinical trial. Br J Anaesth 2020; 124:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smarkusky L, DeCarvalho H, Bermudez A, González-Quintero VH. Acute onset headache complicating labor epidural caused by intrapartum pneumocephalus. Obstet Gynecol 2006; 108:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004; 101:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bateman BT, Mhyre JM, Ehrenfeld J, et al. The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group Research Consortium. Anesth Analg 2013; 116:1380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palot M, Visseaux H, Botmans C, Pire JC. [Epidemiology of complications of obstetrical epidural analgesia]. Cah Anesthesiol 1994; 42:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand 2016; 60:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Estcourt LJ, Malouf R, Hopewell S, et al. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev 2018; 4:CD011980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee LO, Bateman BT, Kheterpal S, et al. Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group. Anesthesiology 2017; 126:1053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy N, Goren O, Cattan A, et al. Neuraxial block for delivery among women with low platelet counts: a retrospective analysis. Int J Obstet Anesth 2018; 35:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauer ME, Toledano RD, Houle T, et al. Lumbar neuraxial procedures in thrombocytopenic patients across populations: A systematic review and meta-analysis. J Clin Anesth 2020; 61:109666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauer ME, Arendt K, Beilin Y, et al. The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia. Anesth Analg 2021; 132:1531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douglas MJ. Platelets, the parturient and regional anesthesia. Int J Obstet Anesth 2001; 10:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauchat JR, Weiniger CF, Sultan P, et al. Society for Obstetric Anesthesia and Perinatology Consensus Statement: Monitoring Recommendations for Prevention and Detection of Respiratory Depression Associated With Administration of Neuraxial Morphine for Cesarean Delivery Analgesia. Anesth Analg 2019; 129:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rawal N, Schött U, Dahlström B, et al. Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine. Anesthesiology 1986; 64:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breen TW, Ransil BJ, Groves PA, Oriol NE. Factors associated with back pain after childbirth. Anesthesiology 1994; 81:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell R, Dundas R, Reynolds F. Long term backache after childbirth: prospective search for causative factors. BMJ 1996; 312:1384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macarthur A, Macarthur C, Weeks S. Epidural anaesthesia and low back pain after delivery: a prospective cohort study. BMJ 1995; 311:1336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macarthur AJ, Macarthur C, Weeks SK. Is epidural anesthesia in labor associated with chronic low back pain? A prospective cohort study. Anesth Analg 1997; 85:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howell CJ, Kidd C, Roberts W, et al. A randomised controlled trial of epidural compared with non-epidural analgesia in labour. BJOG 2001; 108:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howell CJ, Dean T, Lucking L, et al. Randomised study of long term outcome after epidural versus non-epidural analgesia during labour. BMJ 2002; 325:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loughnan BA, Carli F, Romney M, et al. Epidural analgesia and backache: a randomized controlled comparison with intramuscular meperidine for analgesia during labour. Br J Anaesth 2002; 89:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollmén AI, Jouppila R, Jouppila P, et al. Effect of extradural analgesia using bupivacaine and 2-chloroprocaine on intervillous blood flow during normal labour. Br J Anaesth 1982; 54:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes AB, Devoe LD, Wakefield ML, Metheny WP. The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal term labor. Obstet Gynecol 1990; 75:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu S, Gan J, Xing Y, et al. The Effects of Labor Epidural Analgesia on Maternal and Fetal Hemodynamics: A Prospective Observation Study. J Ultrasound Med 2023; 42:2369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reynolds F, Sharma SK, Seed PT. Analgesia in labour and fetal acid-base balance: a meta-analysis comparing epidural with systemic opioid analgesia. BJOG 2002; 109:1344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abrão KC, Francisco RP, Miyadahira S, et al. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial. Obstet Gynecol 2009; 113:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cascio M, Pygon B, Bernett C, Ramanathan S. Labour analgesia with intrathecal fentanyl decreases maternal stress. Can J Anaesth 1997; 44:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sng BL, Leong WL, Zeng Y, et al. Early versus late initiation of epidural analgesia for labour. Cochrane Database Syst Rev 2014; :CD007238.
          </a>
         </li>
         <li class="breakAll">
          American College of Obstetricians and Gynecologists. Obstetric analgesia and anesthesia. ACOG practice bulletin #36. Obstet Gynecol 2002; 100;177.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultan P, Murphy C, Halpern S, Carvalho B. The effect of low concentrations versus high concentrations of local anesthetics for labour analgesia on obstetric and anesthetic outcomes: a meta-analysis. Can J Anaesth 2013; 60:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang TT, Sun S, Huang SQ. Effects of Epidural Labor Analgesia With Low Concentrations of Local Anesthetics on Obstetric Outcomes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg 2017; 124:1571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Damhuis SE, Groen H, Thilaganathan B, et al. Effect of intrapartum epidural analgesia on rate of emergency delivery for presumed fetal compromise: nationwide registry-based cohort study. Ultrasound Obstet Gynecol 2023; 62:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabernée Heijtmeijer ESE, Groen H, Damhuis SE, et al. Epidural analgesia and emergency delivery for presumed fetal compromise: post-hoc analysis of RAVEL multicenter randomized controlled trial. Ultrasound Obstet Gynecol 2023; 62:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohel G, Gonen R, Vaida S, et al. Early versus late initiation of epidural analgesia in labor: does it increase the risk of cesarean section? A randomized trial. Am J Obstet Gynecol 2006; 194:600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CA, McCarthy RJ, Sullivan JT, et al. Early compared with late neuraxial analgesia in nulliparous labor induction: a randomized controlled trial. Obstet Gynecol 2009; 113:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang F, Shen X, Guo X, et al. Epidural analgesia in the latent phase of labor and the risk of cesarean delivery: a five-year randomized controlled trial. Anesthesiology 2009; 111:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CA, Scavone BM, Peaceman AM, et al. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med 2005; 352:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang J, Landy HJ, Branch DW, et al. Contemporary patterns of spontaneous labor with normal neonatal outcomes. Obstet Gynecol 2010; 116:1281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng YW, Shaffer BL, Nicholson JM, Caughey AB. Second stage of labor and epidural use: a larger effect than previously suggested. Obstet Gynecol 2014; 123:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beilin Y, Bodian CA, Weiser J, et al. Effect of labor epidural analgesia with and without fentanyl on infant breast-feeding: a prospective, randomized, double-blind study. Anesthesiology 2005; 103:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           French CA, Cong X, Chung KS. Labor Epidural Analgesia and Breastfeeding: A Systematic Review. J Hum Lact 2016; 32:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson MJ, MacArthur C, Cooper GM, et al. Epidural analgesia and breastfeeding: a randomised controlled trial of epidural techniques with and without fentanyl and a non-epidural comparison group. Anaesthesia 2010; 65:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee AI, McCarthy RJ, Toledo P, et al. Epidural Labor Analgesia-Fentanyl Dose and Breastfeeding Success: A Randomized Clinical Trial. Anesthesiology 2017; 127:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orbach-Zinger S, Landau R, Davis A, et al. The Effect of Labor Epidural Analgesia on Breastfeeding Outcomes: A Prospective Observational Cohort Study in a Mixed-Parity Cohort. Anesth Analg 2019; 129:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heesen P, Halpern SH, Beilin Y, et al. Labor neuraxial analgesia and breastfeeding: An updated systematic review. J Clin Anesth 2021; 68:110105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bader AM, Fragneto R, Terui K, et al. Maternal and neonatal fentanyl and bupivacaine concentrations after epidural infusion during labor. Anesth Analg 1995; 81:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang K, Cao L, Deng Q, et al. The effects of epidural/spinal opioids in labour analgesia on neonatal outcomes: a meta-analysis of randomized controlled trials. Can J Anaesth 2014; 61:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loftus JR, Hill H, Cohen SE. Placental transfer and neonatal effects of epidural sufentanil and fentanyl administered with bupivacaine during labor. Anesthesiology 1995; 83:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter J, Bonello E, Reynolds F. Effect of epidural fentanyl on neonatal respiration. Anesthesiology 1998; 89:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorp JA, Hu DH, Albin RM, et al. The effect of intrapartum epidural analgesia on nulliparous labor: a randomized, controlled, prospective trial. Am J Obstet Gynecol 1993; 169:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dailey PA, Baysinger CL, Levinson G, Shnider SM. Neurobehavioral testing of the newborn infant. Effects of obstetric anesthesia. Clin Perinatol 1982; 9:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halpern SH, Leighton BL, Ohlsson A, et al. Effect of epidural vs parenteral opioid analgesia on the progress of labor: a meta-analysis. JAMA 1998; 280:2105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mark K, LeBeau O, Gibbons M, et al. Rates and clinical implication of transplacental transfer of neuraxial fentanyl to neonate. Am J Obstet Gynecol 2023; 228:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas H, Asskali F, Vettermann J. [Addition of fentanyl to bupivacaine--peridural analgesia in cesarean section]. Anaesthesist 1996; 45:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parate LH, Manjrekar SP, Anandaswamy TC, Manjunath B. The effect of addition of low dose fentanyl to epidural bupivacaine (0.5%) in patients undergoing elective caesarean section: A randomized, parallel group, double blind, placebo controlled study. J Postgrad Med 2015; 61:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olofsson C, Ekblom A, Sköldefors E, et al. Anesthetic quality during cesarean section following subarachnoid or epidural administration of bupivacaine with or without fentanyl. Acta Anaesthesiol Scand 1997; 41:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glasson EJ, Bower C, Petterson B, et al. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004; 61:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiu C, Lin JC, Shi JM, et al. Association Between Epidural Analgesia During Labor and Risk of Autism Spectrum Disorders in Offspring. JAMA Pediatr 2020; 174:1168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKeen DM, Zaphiratos V, Canadian Anesthesiologists’ Society. Lack of evidence that epidural pain relief during labour causes autism spectrum disorder: a position statement of the Canadian Anesthesiologists' Society. Can J Anaesth 2021; 68:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wall-Wieler E, Bateman BT, Hanlon-Dearman A, et al. Association of Epidural Labor Analgesia With Offspring Risk of Autism Spectrum Disorders. JAMA Pediatr 2021; 175:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mikkelsen AP, Greiber IK, Scheller NM, Lidegaard Ø. Association of Labor Epidural Analgesia With Autism Spectrum Disorder in Children. JAMA 2021; 326:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanley GE, Bickford C, Ip A, et al. Association of Epidural Analgesia During Labor and Delivery With Autism Spectrum Disorder in Offspring. JAMA 2021; 326:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kearns RJ, Shaw M, Gromski PS, et al. Association of Epidural Analgesia in Women in Labor With Neonatal and Childhood Outcomes in a Population Cohort. JAMA Netw Open 2021; 4:e2131683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Straub L, Huybrechts KF, Mogun H, Bateman BT. Association of Neuraxial Labor Analgesia for Vaginal Childbirth With Risk of Autism Spectrum Disorder. JAMA Netw Open 2021; 4:e2140458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ren T, Zhang J, Yu Y, et al. Association of labour epidural analgesia with neurodevelopmental disorders in offspring: a Danish population-based cohort study. Br J Anaesth 2022; 128:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy MSQ, Ducharme R, Hawken S, et al. Exposure to Intrapartum Epidural Analgesia and Risk of Autism Spectrum Disorder in Offspring. JAMA Netw Open 2022; 5:e2214273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hegvik TA, Klungsøyr K, Kuja-Halkola R, et al. Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder: a cross-national cohort study of 4.5 million individuals and their siblings. Am J Obstet Gynecol 2023; 228:233.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lumbreras-Marquez MI, Capdeville G, Ferrigno AS, et al. Association of neuraxial labor analgesia with autism spectrum disorder in children: a systematic review and meta-analysis. Int J Obstet Anesth 2022; 52:103577.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4469 Version 75.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11273939" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The effects of an increase of central blood volume before spinal anesthesia for cesarean delivery: a qualitative systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8695107" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Hemodynamic effects of intrathecal fentanyl in nonlaboring term parturients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10422932" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Bupivacaine augments intrathecal fentanyl for labor analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23076897" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Combined spinal-epidural versus epidural analgesia in labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31704251" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Adverse side effects and route of administration of opioids in combined spinal-epidural analgesia for labour: a meta-analysis of randomised trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10992845" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Randomized study of intravenous fluid preload before epidural analgesia during labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10690153" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Opioid-induced pruritus: repeated vs single dose ondansetron administration in preventing pruritus after intrathecal morphine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10866907" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15321438" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9842818" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Intrathecal bupivacaine reduces pruritus and prolongs duration of fentanyl analgesia during labor: a prospective, randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11012498" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The effect of the addition of ropivacaine or bupivacaine upon pruritus induced by intrathecal fentanyl in labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9175960" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Extradural pain relief in labour: bupivacaine sparing by extradural fentanyl is dose dependent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10839903" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The dose-response of intrathecal sufentanil added to bupivacaine for labor analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10439751" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Analgesia, pruritus, and ventilation exhibit a dose-response relationship in parturients receiving intrathecal fentanyl during labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18502360" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9952150" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Dose-response relationship of intrathecal morphine for postcesarean analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23921652" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25861787" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Neuraxial opioid-induced itch and its pharmacological antagonism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21785031" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Use of pure opioid antagonists for management of opioid-induced pruritus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26650717" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Nalbuphine for Treatment of Opioid-induced Pruritus: A Systematic Review of Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1416128" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Nalbuphine is better than naloxone for treatment of side effects after epidural morphine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9366459" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37455197" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Pharmacological agents for prevention of pruritus in women undergoing Caesarean delivery with neuraxial morphine: a systematic review and Bayesian network meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11412287" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19535708" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8067559" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Complications of labor analgesia: epidural versus combined spinal epidural techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23066001" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Impact of data by Fujii and colleagues on the meta-analysis of metoclopramide for antiemetic prophylaxis in women undergoing Caesarean delivery under neuraxial anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22307240" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22344239" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Dexamethasone for the prophylaxis of postoperative nausea and vomiting associated with neuraxial morphine administration: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29226971" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17717237" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19945849" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23965210" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28185794" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8773867" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Epidural morphine vs hydromorphone in post-caesarean section patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15166570" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Intrathecal opioids and lower urinary tract function: a urodynamic evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16978160" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Post-void residual volume in labor: a prospective study comparing parturients with and without epidural analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29781504" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Epidural versus non-epidural or no analgesia for pain management in labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18987057" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Urinary catheterization in labour with high-dose vs mobile epidural analgesia: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18648241" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Temperature monitoring and perioperative thermoregulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30945105" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15477051" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Incidence and characteristics of failures in obstetric neuraxial analgesia and anesthesia: a retrospective analysis of 19,259 deliveries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19046867" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Inadequate pain relief with labor epidurals: a multivariate analysis of associated factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24845921" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28233414" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The CAPS Study: incidence, management and outcomes of cardiac arrest in pregnancy in the UK: a prospective, descriptive study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21797856" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Incidence of post-dural puncture headache in research volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12734154" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18458543" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Management of postdural puncture headache in the obstetric patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15321606" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : An audit of epidural blood patch after accidental dural puncture with a Tuohy needle in obstetric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17339157" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Effective epidural blood patch volumes for postdural puncture headache in Taiwanese women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21596867" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The volume of blood for epidural blood patch in obstetrics: a randomized, blinded clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25721827" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Lumbar blood patching for proximal CSF leaks: where does the blood go?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Spenopalatine ganglion block: a simple block in the management of chronic pain
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25340493" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Sphenopalatine ganglion block: a safer alternative to epidural blood patch for postdural puncture headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30063655" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Topical Sphenopalatine Ganglion Block Compared With Epidural Blood Patch for Postdural Puncture Headache Management in Postpartum Patients: A Retrospective Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32303377" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Sphenopalatine ganglion block for the treatment of postdural puncture headache: a randomised, blinded, clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17018506" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Acute onset headache complicating labor epidural caused by intrapartum pneumocephalus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15448529" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Severe neurological complications after central neuraxial blockades in Sweden 1990-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22504213" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group Research Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8087639" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : [Epidemiology of complications of obstetrical epidural analgesia].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26876878" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Nationwide incidence of serious complications of epidural analgesia in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7978443" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Anticoagulants and spinal-epidural anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29709077" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28383323" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29502991" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Neuraxial block for delivery among women with low platelet counts: a retrospective analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31810860" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Lumbar neuraxial procedures in thrombocytopenic patients across populations: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33861047" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Platelets, the parturient and regional anesthesia
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31082964" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Society for Obstetric Anesthesia and Perinatology Consensus Statement: Monitoring Recommendations for Prevention and Detection of Respiratory Depression Associated With Administration of Neuraxial Morphine for Cesarean Delivery Analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3946806" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8042807" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Factors associated with back pain after childbirth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8646094" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Long term backache after childbirth: prospective search for causative factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7496283" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Epidural anaesthesia and low back pain after delivery: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9356101" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Is epidural anesthesia in labor associated with chronic low back pain? A prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11213000" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : A randomised controlled trial of epidural compared with non-epidural analgesia in labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12183305" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Randomised study of long term outcome after epidural versus non-epidural analgesia during labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12402727" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Epidural analgesia and backache: a randomized controlled comparison with intramuscular meperidine for analgesia during labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7104133" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Effect of extradural analgesia using bupivacaine and 2-chloroprocaine on intervillous blood flow during normal labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2183109" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal term labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37269218" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The Effects of Labor Epidural Analgesia on Maternal and Fetal Hemodynamics: A Prospective Observation Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12504969" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Analgesia in labour and fetal acid-base balance: a meta-analysis comparing epidural with systemic opioid analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19104358" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9187779" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Labour analgesia with intrathecal fentanyl decreases maternal stress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25300169" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Early versus late initiation of epidural analgesia for labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25300169" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Early versus late initiation of epidural analgesia for labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23925722" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : The effect of low concentrations versus high concentrations of local anesthetics for labour analgesia on obstetric and anesthetic outcomes: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27828798" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Effects of Epidural Labor Analgesia With Low Concentrations of Local Anesthetics on Obstetric Outcomes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37448203" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Effect of intrapartum epidural analgesia on rate of emergency delivery for presumed fetal compromise: nationwide registry-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37448200" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Epidural analgesia and emergency delivery for presumed fetal compromise: post-hoc analysis of RAVEL multicenter randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16522386" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Early versus late initiation of epidural analgesia in labor: does it increase the risk of cesarean section? A randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19384122" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Early compared with late neuraxial analgesia in nulliparous labor induction: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19741492" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Epidural analgesia in the latent phase of labor and the risk of cesarean delivery: a five-year randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15716559" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The risk of cesarean delivery with neuraxial analgesia given early versus late in labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21099592" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Contemporary patterns of spontaneous labor with normal neonatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24499753" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Second stage of labor and epidural use: a larger effect than previously suggested.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16306734" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Effect of labor epidural analgesia with and without fentanyl on infant breast-feeding: a prospective, randomized, double-blind study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27121239" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Labor Epidural Analgesia and Breastfeeding: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19912160" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Epidural analgesia and breastfeeding: a randomised controlled trial of epidural techniques with and without fentanyl and a non-epidural comparison group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28926440" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Epidural Labor Analgesia-Fentanyl Dose and Breastfeeding Success: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31425221" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : The Effect of Labor Epidural Analgesia on Breastfeeding Outcomes: A Prospective Observational Cohort Study in a Mixed-Parity Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33069970" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Labor neuraxial analgesia and breastfeeding: An updated systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7574018" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Maternal and neonatal fentanyl and bupivacaine concentrations after epidural infusion during labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25011701" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : The effects of epidural/spinal opioids in labour analgesia on neonatal outcomes: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7631952" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Placental transfer and neonatal effects of epidural sufentanil and fentanyl administered with bupivacaine during labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9667297" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Effect of epidural fentanyl on neonatal respiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8238138" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : The effect of intrapartum epidural analgesia on nulliparous labor: a randomized, controlled, prospective trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7039933" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Neurobehavioral testing of the newborn infant. Effects of obstetric anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9875879" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Effect of epidural vs parenteral opioid analgesia on the progress of labor: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36565903" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Rates and clinical implication of transplacental transfer of neuraxial fentanyl to neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8765865" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : [Addition of fentanyl to bupivacaine--peridural analgesia in cesarean section].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25511214" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : The effect of addition of low dose fentanyl to epidural bupivacaine (0.5%) in patients undergoing elective caesarean section: A randomized, parallel group, double blind, placebo controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9113175" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Anesthetic quality during cesarean section following subarachnoid or epidural administration of bupivacaine with or without fentanyl.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184241" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Perinatal factors and the development of autism: a population study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33044486" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Association Between Epidural Analgesia During Labor and Risk of Autism Spectrum Disorders in Offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33108637" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Lack of evidence that epidural pain relief during labour causes autism spectrum disorder: a position statement of the Canadian Anesthesiologists' Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33871547" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Association of Epidural Labor Analgesia With Offspring Risk of Autism Spectrum Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34581738" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Association of Labor Epidural Analgesia With Autism Spectrum Disorder in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34581736" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Association of Epidural Analgesia During Labor and Delivery With Autism Spectrum Disorder in Offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34709386" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Association of Epidural Analgesia in Women in Labor With Neonatal and Childhood Outcomes in a Population Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34935925" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Association of Neuraxial Labor Analgesia for Vaginal Childbirth With Risk of Autism Spectrum Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34893316" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Association of labour epidural analgesia with neurodevelopmental disorders in offspring: a Danish population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35616937" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Exposure to Intrapartum Epidural Analgesia and Risk of Autism Spectrum Disorder in Offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35973476" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder: a cross-national cohort study of 4.5 million individuals and their siblings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35908498" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Association of neuraxial labor analgesia with autism spectrum disorder in children: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
